Evidence map›Paper›PMID 39360170›Full record

ArticleGE Portuguese journal of gastroenterology2024

Risk Factors in Serrated Pathway Lesions: N-Glycosylation Profile as a Potential Biomarker of Progression to Malignancy.

Henrique Fernandes-Mendes, Catarina M Azevedo, Mónica Garrido, Carolina Lemos, Isabel Pedroto, Salomé S Pinho, Ricardo Marcos-Pinto, Ângela Fernandes

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in GE Portuguese journal of gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Henrique Fernandes-MendesDepartment of Gastroenterology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Catarina M AzevedoInstituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
Mónica GarridoDepartment of Gastroenterology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
Carolina LemosInstituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
Isabel PedrotoDepartment of Gastroenterology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Salomé S PinhoInstitute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Ricardo Marcos-PintoDepartment of Gastroenterology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Ângela FernandesInstitute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The serrated pathway contributes to interval colorectal cancers, highlighting the need for new biomarkers to assess lesion progression risk. The β1,6-GlcNAc branched Methods: A retrospective cohort study was performed with data from 53 colonoscopies (48 patients). Sixty-three serrated pathway lesions (SPLs) were characterized based on Results: Increased β1,6-GlcNAc branched Conclusions: We identified an association between an abnormal glycoprofile and several clinical risk factors, proposing the

Indexed as

BiomarcadorBiomarkerCancro colorretalColorectal cancerLesões serreadasN-glicanos β1,6-GlcNAc ramificadosN-glicosilaçãoN-glycosylationSerrated lesionsSerrated pathwayVia serreadaβ1,6-GlcNAc branched N-glycans

Identifiers

PMID39360170
PMCPMC11444659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.